Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06917001 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Clinical Trial Evaluating Safety and Efficacy of Resomelagon on Dengue Infection (RESOVIR-2)

Study acronym: RESOVIR-2
StatusRecruiting
PhasePhase 2
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Recruitment opened Show 6 more changesShow less
    • Start date changed from estimate of Feb 2026 to Mar 20, 2026
    • Secondary endpoints: details revised at 1 of 3 entries
    • Study description expanded, about 173 words
    • Site details revised at 2 of 2 sites
    • Publications: details revised at 16 of 16 entries
    • Eligibility criteria expanded, about 4 words
  2. Start date: Apr 2025 to Feb 2026v2
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The goal of this clinical trial is to understand if Resomelagon can treat adult patients with Dengue virus infection. The main questions the investigators aim to answer are: Is Resomelagon safe to use in patients with Dengue? Is Resomelagon able to reduce the duration of illness? (defined by clinical and laboratory criteria) Participants will be allocated to Resomelagon or placebo groups in this study and asked to take the medication and submitted to blood tests.
Trial Details
NCT Number NCT06917001
Lead Sponsor Federal University of Minas Gerais
Collaborators: Instituto Nacional de Ciência e Tecnologia em Dengue (INCT em Dengue)
Conditions
(from sponsor)		 Dengue Fever
Related terms Dengue
Enrollment 120 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov